What happens when statins like Lipitor inhibit HMG CoA reductase?
HMG CoA reductase is an enzyme crucial for cholesterol production in the liver. Statins, like Lipitor, specifically target this enzyme to inhibit HMG CoA reductase activity.
[1] This inhibition reduces the liver's ability to produce cholesterol, which in turn decreases the amount of cholesterol available for incorporation into low-density lipoprotein (LDL) particles.
How does HMG CoA reductase inhibition affect LDL levels?
Studies have shown that statins like Lipitor can lower LDL levels by as much as 40-60% when used in standard doses [2]. The reduction in LDL levels is largely due to the decreased availability of cholesterol for LDL particle formation.
What is the role of LDL in cardiovascular disease?
Elevated LDL levels are associated with an increased risk of cardiovascular disease, including atherosclerosis, heart attack, and stroke [3]. The reduction of LDL levels through HMG CoA reductase inhibition can help mitigate this risk.
Can HMG CoA reductase inhibition affect other lipids besides LDL?
Yes, statins like Lipitor can also have an impact on other lipids, including triglycerides and high-density lipoprotein (HDL) cholesterol. While the exact effects may vary depending on individual circumstances, HMG CoA reductase inhibition tends to increase HDL and decrease triglyceride levels [4].
Sources:
[1] DrugPatentWatch.com: HMG-CoA Reductase Inhibitors - Patent Expire Dates
[2] Lipitor (atorvastatin calcium) prescribing information. Pfizer Inc.
[3] Centers for Disease Control and Prevention. Lipoproteins.
[4] Statin Treatment and Risk of Stroke: A Systematic Review and Meta-Analysis. The Lancet (2016)
Citations:
1. DrugPatentWatch.com: HMG-CoA Reductase Inhibitors - Patent Expire Dates
2. Lipitor (atorvastatin calcium) prescribing information. Pfizer Inc.
3. Centers for Disease Control and Prevention. Lipoproteins.
4. Statin Treatment and Risk of Stroke: A Systematic Review and Meta-Analysis. The Lancet (2016)